[HTML][HTML] Novel agents for the pharmacological treatment of alcohol use disorder

EM Burnette, SJ Nieto, EN Grodin, LR Meredith… - Drugs, 2022 - Springer
Alcohol use disorder (AUD) is a highly prevalent but severely under-treated disorder, with
only three widely-approved pharmacotherapies. Given that AUD is a very heterogeneous …

[HTML][HTML] Animal models of compulsion alcohol drinking: why we love quinine-resistant intake and what we learned from it

T De Oliveira Sergio, RM Frasier, FW Hopf - Frontiers in Psychiatry, 2023 - frontiersin.org
Alcohol Use Disorder (AUD) ranks among the most prevalent mental disorders, extracting~
$250 billion/year in the US alone and producing myriad medical and social harms. Also, the …

Noradrenergic circuits and signaling in substance use disorders

AM Downs, ZA McElligott - Neuropharmacology, 2022 - Elsevier
The central noradrenergic system innervates almost all regions of the brain and, as such, is
well positioned to modulate many neural circuits implicated in behaviors and physiology …

Noradrenergic targets for the treatment of alcohol use disorder

CL Haass-Koffler, RM Swift, L Leggio - Psychopharmacology, 2018 - Springer
The role of norepinephrine (NE) in the development of alcohol use disorder (AUD) has been
studied over the past several decades. However, the NE system has been largely ignored …

New approved and emerging pharmacological approaches to alcohol use disorder: a review of clinical studies

KC Morley, CJ Perry, J Watt, T Hurzeler… - Expert Opinion on …, 2021 - Taylor & Francis
Abstract introduction: The number of medications approved for AUD is small and they
generally have limited efficacy. We need new pharmacotherapies for the management of …

Alterations in resting-state functional connectivity in substance use disorders and treatment implications

CE Wilcox, CC Abbott, VD Calhoun - Progress in Neuro …, 2019 - Elsevier
Substance use disorders (SUD) are diseases of the brain, characterized by aberrant
functioning in the neural circuitry of the brain. Resting state functional connectivity (rsFC) can …

A randomized, placebo-controlled, clinical trial of prazosin for the treatment of alcohol use disorder

CE Wilcox, JS Tonigan, MP Bogenschutz… - Journal of addiction …, 2018 - journals.lww.com
Objectives: The noradrenergic system plays an important role in the pathophysiology of
alcohol use disorder (AUD). Medications in this class may reduce drinking. Our aims were to …

Treating posttraumatic stress disorder and alcohol use disorder comorbidity: Current pharmacological therapies and the future of MDMA-integrated psychotherapy

BJ Gully, E Eaton, C Capone… - Journal of …, 2023 - journals.sagepub.com
Posttraumatic stress disorder (PTSD) and alcohol use disorder (AUD) frequently co-occur in
patients who have experienced trauma. This comorbidity leads to a vicious cycle where …

Alcohol addiction-the safety of available approved treatment options

M Antonelli, A Ferrulli, L Sestito… - Expert opinion on …, 2018 - Taylor & Francis
ABSTRACT Introduction: Alcohol Use Disorders (AUD) is a leading cause of mortality and
morbidity worldwide. At present disulfiram, naltrexone and acamprosate are approved for …

Effects of prazosin on provoked alcohol craving and autonomic and neuroendocrine response to stress in alcohol use disorder

V Milivojevic, GA Angarita, G Hermes… - Alcoholism: Clinical …, 2020 - Wiley Online Library
Background Chronic alcohol use results in changes to stress biology and autonomic arousal
contributing to acute alcohol withdrawal symptoms, neuroendocrine tolerance of the …